annual EBITDA:
-$138.53M-$87.37M(-170.77%)Summary
- As of today (August 31, 2025), VRNA annual EBITDA is -$138.53 million, with the most recent change of -$87.37 million (-170.77%) on December 31, 2024.
- During the last 3 years, VRNA annual EBITDA has fallen by -$83.91 million (-153.63%).
- VRNA annual EBITDA is now -1154308.33% below its all-time high of -$12.00 thousand, reached on December 31, 2005.
Performance
VRNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$13.76M+$23.82M(+236.76%)Summary
- As of today (August 31, 2025), VRNA quarterly EBITDA is $13.76 million, with the most recent change of +$23.82 million (+236.76%) on June 1, 2025.
- Over the past year, VRNA quarterly EBITDA has increased by +$81.99 million (+120.17%).
- VRNA quarterly EBITDA is now at all-time high.
Performance
VRNA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$55.03M+$81.99M(+59.84%)Summary
- As of today (August 31, 2025), VRNA TTM EBITDA is -$55.03 million, with the most recent change of +$81.99 million (+59.84%) on June 1, 2025.
- Over the past year, VRNA TTM EBITDA has increased by +$75.23 million (+57.75%).
- VRNA TTM EBITDA is now -4356.54% below its all-time high of -$1.23 million, reached on June 30, 2016.
Performance
VRNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VRNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -170.8% | +120.2% | +57.8% |
| 3 y3 years | -153.6% | +168.2% | +17.3% |
| 5 y5 years | -246.5% | +226.8% | -7.0% |
VRNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -170.8% | at low | at high | +120.2% | at high | +64.5% |
| 5 y | 5-year | -246.5% | at low | at high | +120.2% | -23.9% | +64.5% |
| alltime | all time | <-9999.0% | at low | at high | +120.2% | -4356.5% | +64.5% |
VRNA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $13.76M(-236.8%) | -$55.03M(-59.8%) |
| Mar 2025 | - | -$10.06M(-43.8%) | -$137.02M(-11.0%) |
| Dec 2024 | -$138.53M(+170.8%) | -$17.91M(-56.1%) | -$153.88M(-0.7%) |
| Sep 2024 | - | -$40.82M(-40.2%) | -$155.01M(+19.0%) |
| Jun 2024 | - | -$68.23M(+153.5%) | -$130.26M(+81.2%) |
| Mar 2024 | - | -$26.92M(+41.3%) | -$71.87M(+7.0%) |
| Dec 2023 | -$51.16M(-24.0%) | -$19.05M(+18.6%) | -$67.19M(+6.4%) |
| Sep 2023 | - | -$16.06M(+63.2%) | -$63.15M(+2.0%) |
| Jun 2023 | - | -$9.84M(-55.8%) | -$61.93M(-14.3%) |
| Mar 2023 | - | -$22.24M(+48.2%) | -$72.26M(-3.4%) |
| Dec 2022 | -$67.29M(+23.2%) | -$15.01M(+1.1%) | -$74.78M(-15.1%) |
| Sep 2022 | - | -$14.84M(-26.4%) | -$88.11M(+32.3%) |
| Jun 2022 | - | -$20.17M(-18.6%) | -$66.58M(-10.9%) |
| Mar 2022 | - | -$24.76M(-12.6%) | -$74.75M(+2.7%) |
| Dec 2021 | -$54.62M(-15.1%) | -$28.34M(-523.7%) | -$72.77M(+63.8%) |
| Sep 2021 | - | $6.69M(-123.6%) | -$44.43M(-38.7%) |
| Jun 2021 | - | -$28.34M(+24.4%) | -$72.44M(+31.8%) |
| Mar 2021 | - | -$22.78M(+6.8%) | -$54.96M(-1.4%) |
| Dec 2020 | -$64.34M(+60.9%) | - | - |
| Sep 2020 | - | -$21.32M(+96.4%) | -$55.75M(+8.4%) |
| Jun 2020 | - | -$10.85M(-24.3%) | -$51.44M(-8.0%) |
| Mar 2020 | - | -$14.33M(+55.1%) | -$55.93M(+8.5%) |
| Dec 2019 | -$39.98M | -$9.24M(-45.7%) | -$51.57M(-0.2%) |
| Sep 2019 | - | -$17.01M(+10.8%) | -$51.68M(+18.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$15.35M(+53.9%) | -$43.45M(+21.5%) |
| Mar 2019 | - | -$9.97M(+6.6%) | -$35.76M(+5.4%) |
| Dec 2018 | -$30.36M(-10.2%) | -$9.35M(+6.5%) | -$33.93M(-12.2%) |
| Sep 2018 | - | -$8.78M(+14.7%) | -$38.67M(-4.5%) |
| Jun 2018 | - | -$7.65M(-6.1%) | -$40.49M(+6.0%) |
| Mar 2018 | - | -$8.15M(-42.2%) | -$38.20M(+15.1%) |
| Dec 2017 | -$33.79M(+370.2%) | -$14.09M(+32.9%) | -$33.20M(+56.3%) |
| Sep 2017 | - | -$10.60M(+97.8%) | -$21.23M(+60.4%) |
| Jun 2017 | - | -$5.36M(+70.7%) | -$13.24M(+45.3%) |
| Mar 2017 | - | -$3.14M(+47.9%) | -$9.11M(+52.6%) |
| Dec 2016 | -$7.19M(-45.4%) | -$2.12M(-18.7%) | -$5.97M(+55.2%) |
| Sep 2016 | - | -$2.61M(+111.5%) | -$3.85M(+211.5%) |
| Jun 2016 | - | -$1.23M | -$1.23M |
| Dec 2015 | -$13.17M(+126.2%) | - | - |
| Dec 2014 | -$5.82M(+27.0%) | - | - |
| Dec 2013 | -$4.58M(+11.0%) | - | - |
| Dec 2012 | -$4.13M(+45.8%) | - | - |
| Dec 2011 | -$2.83M(-1.4%) | - | - |
| Dec 2010 | -$2.87M(+12.6%) | - | - |
| Dec 2009 | -$2.55M(+18.9%) | - | - |
| Dec 2008 | -$2.15M(-16.2%) | - | - |
| Dec 2007 | -$2.56M(+95.5%) | - | - |
| Dec 2006 | -$1.31M(>+9900.0%) | - | - |
| Dec 2005 | -$12.00K | - | - |
FAQ
- What is Verona Pharma plc annual EBITDA?
- What is the all time high annual EBITDA for Verona Pharma plc?
- What is Verona Pharma plc annual EBITDA year-on-year change?
- What is Verona Pharma plc quarterly EBITDA?
- What is the all time high quarterly EBITDA for Verona Pharma plc?
- What is Verona Pharma plc quarterly EBITDA year-on-year change?
- What is Verona Pharma plc TTM EBITDA?
- What is the all time high TTM EBITDA for Verona Pharma plc?
- What is Verona Pharma plc TTM EBITDA year-on-year change?
What is Verona Pharma plc annual EBITDA?
The current annual EBITDA of VRNA is -$138.53M
What is the all time high annual EBITDA for Verona Pharma plc?
Verona Pharma plc all-time high annual EBITDA is -$12.00K
What is Verona Pharma plc annual EBITDA year-on-year change?
Over the past year, VRNA annual EBITDA has changed by -$87.37M (-170.77%)
What is Verona Pharma plc quarterly EBITDA?
The current quarterly EBITDA of VRNA is $13.76M
What is the all time high quarterly EBITDA for Verona Pharma plc?
Verona Pharma plc all-time high quarterly EBITDA is $13.76M
What is Verona Pharma plc quarterly EBITDA year-on-year change?
Over the past year, VRNA quarterly EBITDA has changed by +$81.99M (+120.17%)
What is Verona Pharma plc TTM EBITDA?
The current TTM EBITDA of VRNA is -$55.03M
What is the all time high TTM EBITDA for Verona Pharma plc?
Verona Pharma plc all-time high TTM EBITDA is -$1.23M
What is Verona Pharma plc TTM EBITDA year-on-year change?
Over the past year, VRNA TTM EBITDA has changed by +$75.23M (+57.75%)